TRIM55 suppresses malignant biological behavior of lung adenocarcinoma cells by increasing protein degradation of Snail1

References

• Siegel RL, Miller KD, Fuchs HE, Jemal A. 2021 Jan. Cancer Statistics. CA Cancer J Clin. 71(1):7–33. 10.3322/caac.21654.
   PubMed Web of Science ®Google Scholar
• Williams DE, Pairolero PC, Davis CS, Bernatz PE, Spencer Payne W, Taylor WF, Uhlenhopp MA, Fontana RS. Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg. 1981 Jul;82(1):70–76. doi:10.1016/S0022-5223(19)39389-4.
   PubMed Web of Science ®Google Scholar
• Wang X, Adjei AA. 2015 Jun. Lung cancer and metastasis: new opportunities and challenges. Cancer Metastasis Rev. 34(2):169–171. 10.1007/s10555-015-9562-4.
   PubMed Web of Science ®Google Scholar
• Perera S, Holt MR, Mankoo BS, Gautel M. 2011 Mar 1. Developmental regulation of MURF ubiquitin ligases and autophagy proteins nbr1, p62/SQSTM1 and LC3 during cardiac myofibril assembly and turnover. Dev Biol. 351(1):46–61. 10.1016/j.ydbio.2010.12.024.
   PubMed Web of Science ®Google Scholar
• Li X, Huang L, Gao W. Overexpression of Tripartite Motif Conaining 55 (TRIM55) Inhibits Migration and Invasion of Hepatocellular Carcinoma (HCC) Cells via Epithelial-Mesenchymal Transition and Matrix Metalloproteinase-2 (MMP2). Medical Sci Monitor: Int Medical J Exp Clinical Res. 2019 Jan 27;25:771–777. doi:10.12659/msm.910984.
   Google Scholar
• Leng Z, Xia Q, Chen J, Li Y, Xu J, Zhao E, Zheng H, Ai W, Dong J. 2018. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer. Cell Physiol Biochem. 46(2):860–872. 10.1159/000488743.
   PubMedGoogle Scholar
• Irollo E, Pirozzi G. CD133: to be or not to be, is this the real question? Am J Transl Res. 2013 Sep 25;5(6):563–581.
   PubMed Web of Science ®Google Scholar
• Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R, et al. 2008 Mar. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 15(3):504–514. DOI:10.1038/sj.cdd.4402283.
   PubMed Web of Science ®Google Scholar
• Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. 2004 Nov 18. Identification of human brain tumour initiating cells. Nature. 432(7015):396–401. 10.1038/nature03128.
   PubMed Web of Science ®Google Scholar
• Bussolati B, Bruno S, Grange C, Buttiglieri S, Deregibus MC, Cantino D, Camussi G. 2005 Feb. Isolation of renal progenitor cells from adult human kidney. Am J Pathol. 166(2):545–555. 10.1016/s0002-9440(10)62276-6.
   PubMed Web of Science ®Google Scholar
• Florek M, Haase M, Marzesco AM, Freund D, Ehninger G, Huttner WB, Corbeil D. 2005 Jan. Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res. 319(1):15–26. 10.1007/s00441-004-1018-z.
   PubMed Web of Science ®Google Scholar
• Qu H, Li R, Liu Z, Zhang J, Luo R. Prognostic value of cancer stem cell marker CD133 expression in non-small cell lung cancer: a systematic review. Int J Clin Exp Pathol. 2013;6(11):2644–2650.
   PubMed Web of Science ®Google Scholar
• Yoshida A, Hsu LC, Davé V. 1992. Retinal oxidation activity and biological role of human cytosolic aldehyde dehydrogenase. Enzyme. 46(4–5):239–244. 10.1159/000468794.
   PubMedGoogle Scholar
• Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, Fields JZ, Wicha MS, Boman BM. 2009 Apr 15. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 69(8):3382–3389. 10.1158/0008-5472.Can-08-4418.
   PubMed Web of Science ®Google Scholar
• Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, Xing L, Wang H, Liu Z, Su Y, Stass SA, et al. 2009 Mar. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Molecular Cancer Res: MCR. 7(3):330–338. DOI:10.1158/1541-7786.Mcr-08-0393.
   PubMed Web of Science ®Google Scholar
• Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, et al. 2007 Nov. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 1(5):555–567. DOI:10.1016/j.stem.2007.08.014.
   PubMed Web of Science ®Google Scholar
• Reverdy C, Conrath S, Lopez R, Planquette C, Atmanene C, Collura V, Harpon J, Battaglia V, Vivat V, Sippl W, et al. 2012 Apr 20. Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme. Chem Biol. 19(4):467–477. 10.1016/j.chembiol.2012.02.007.
   PubMedGoogle Scholar
• Yau RG, Doerner K, Castellanos ER, Haakonsen DL, Werner A, Wang N, Yang XW, Martinez-Martin N, Matsumoto ML, Dixit VM, et al. 2017 Nov 2. Assembly and Function of Heterotypic Ubiquitin Chains in Cell-Cycle and Protein Quality Control. Cell. 171(4):918–933.e20. 10.1016/j.cell.2017.09.040.
   PubMed Web of Science ®Google Scholar
• Heger K, Wickliffe KE, Ndoja A, Zhang J, Murthy A, Dugger DL, Maltzman A, de Sousa E Melo F, Hung J, Zeng Y, et al. 2018 Jul. OTULIN limits cell death and inflammation by deubiquitinating LUBAC. Nature. 559(7712):120–124. DOI:10.1038/s41586-018-0256-2.
   PubMed Web of Science ®Google Scholar
• Zou Q, Jin J, Hu H, Li HS, Romano S, Xiao Y, Nakaya M, Zhou X, Cheng X, Yang P, et al. 2014 Jun. USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses. Nat Immunol. 15(6):562–570. DOI:10.1038/ni.2885.
   PubMed Web of Science ®Google Scholar
• Zeman MK, Lin JR, Freire R, Cimprich KA. 2014 Jul 21. DNA damage-specific deubiquitination regulates Rad18 functions to suppress mutagenesis. J Cell Biol. 206(2):183–197. 10.1083/jcb.201311063.
   PubMed Web of Science ®Google Scholar
• Fan Q, Wang Q, Cai R, Yuan H, Xu M. 2020. The ubiquitin system: orchestrating cellular signals in non-small-cell lung cancer. Cell Mol Biol Lett. 25(1):1. 10.1186/s11658-019-0193-6.
   PubMed Web of Science ®Google Scholar
• Barrallo-Gimeno A, Nieto MA. 2005 Jul. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development (Cambridge, England). 132(14):3151–3161. 10.1242/dev.01907.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang G, Zhang H, Zhang F, Zhou B, Ning F, Wang H-S, Cai S-H, Du J. Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway. Eur J Pharmacol. 2014 Jan 15;723:156–166. doi:10.1016/j.ejphar.2013.12.004.
   PubMed Web of Science ®Google Scholar